|
Central Retinal Artery
Occlusion
By Christiane Haddad, MD
Central retinal
artery occlusive disease (CRAO) is one of the most sudden and
dramatic events seen in ophthalmology, though a less frequent
chronic form also exists. It remains a disease of poor visual
prognosis despite a multitude of studies and experimental trials.
CAUSES
The most common
association is atherosclerosis followed by arterial hypertension.
Carotid artery disease occurs in 45%. The difference in etiology
depends on age; if presentation is at less than 30 years, it is
more associated with migraine, trauma and coagulation disorders.
I. Embolization
A.
Emboli from the heart can be:
-
calcific, from aortic or mitral valve calcifications
-
vegetations, from bacterial endocarditis
-
thrombi, after myocardial infarction ‘mural thrombi’ and with
mitral valve prolapse
-
myxomatous, from atrial myxomas mainly to the left eye
B.
Carotid artery disease: mainly due to atheromatous ulceration
at the bifurcation of external and internal carotids. It is usually
associated with chronic obstuction. Emboli can be:
-
cholesterol, yellow ‘Hollenhorst plaques’ at arteriolar
bifurcations, usually asymptomatic
-
fibrinoplatelet, multiple dull gray emboli causing transient
ischemic attacks (amaurosis fugax), with sudden loss of vision for 2
to 10 min. described as a curtain,or complete obstuction
-
calcific, which are much more dangerous than the previous two
because can cause permanent occlusion
II. Vaso-obliteration
A.
Atherosclerosis, most common cause of CRAO
B.
Periarteritis, with systemic vasculitidies like systemic
lupus and polyarteritis nodosa
C.
Hematologic disorders, like antiphospholipid syndrome and
protein C and S deficiencies
D.
Retinal migraine, a rare cause, usually a diagnosis of
exclusion
PRESENTATION
Presentation is usually with a sudden painless loss of vision. The
onset of obstruction is most often between midnight and 6 am and
second most often from 6am to noon. Vision at presentation is
usually counting fingers to light perception and often remains so
regardless of treatmant. Studies have shown that about 35% get a VA
of 20/200 or better and 20% have 20/40 or better. On average, the
age range is between the 5th and 6th decades.
The
central retinal artery supplies the inner 2/3 rd of the retina, the
outer 1/3 rd being supplied by the choroidal circulation. The most
common site of obstruction is at the lamina cribrosa. Experiments
have shown that the critical time after which irreversible damage
occurs is about 90-100 min.
CLINICAL SIGNS
-
Afferent pupillary defect (APD) or Marcus Gunn pupil
-
The retina appears white because of intracellular edema
except at the fovea where it is thin and the choroid shows giving a
‘cherry red spot,’ but this is not a pathognomonic sign. In animal
models, it was seen as early as 30 min after obstruction.
-
Narrowing and irregularities of the arterioles and venules
-
In 1/5th of patients, a portion of the
papillomacular bundle is supplied by a cilioretinal arteriole from
the ciliary circulation. This may preserve central vision.
-
In few weeks, the white retina and cherry red spot disappear,
optic atrophy occurs, foveal light reflect is absent, and arterial
collaterals can develop.
-
Fluorescein angiography shows a marked delay in filling of
the CRA and masfing of the choroidal hyperfluorescence. Venous
filling is also slowed.
-
Visual field defects are usually profound, sometimes sparing
a small portion of the temporal visual field.
BRANCH RETINAL
ARTERY OCCLUSION
It is caused
mostly by emboli and gives altitudinal visual field defects. The
retina appears white in the area of supply of the artery.
Recanalization may leave only subtle changes on exam.
CILIORETINAL ARTERY OCCLUSION
This artey is
present in about 30% of people, arising from the posterior ciliary
circulation. Obstuction causes retinal pallor in the posterior pole
and maybe:
-
isolated, at young age associated with systemic vasculitis
and good prognosis
-
with CRVO, also at young age; prognosis is as with
non-ischemic CRVO.
-
with anterior ischemic optic neuropathy, usually in the
elderly with giant cell arteritis and poor prognosis
OPHTHALMIC
ARTERY OCCLUSION
It can be due
to systemic cardiovascular diseases as CRAO or to local factors such
as retrobulbar anesthesia or orbital disorders. Presentation is with
a total APD, bare or no light perception, intense retinal whitening
+/- cherry red spot and marked defects of retinal and choroidal
perfusion on fluorescein angiography.
CHRONIC
ARTERIAL OBSTRUCTION
It is usually
due to carotid artery disease, mainly atherosclerosis causing
amaurosis fugax as described above and ocular ischemia syndromes (
unilateral retinopathy with cotton wool spots, dilatded artries and
veins, sometimes dot and blot hemorrhages and microaneurysms). It
can also be caused by emboli as mentioned above.
TREATMENT OF
CRAO
Results of treatment remain unsatisfactory. The goal is to restore
blood flow as soon as possible in all cases seen within 48 hours.
This includes the following:
-
supine position, helps maintain circulation
-
ocular massage, intermittently for at least 15 min, to
increase blood flow, decrease intraocular pressure(IOP) and possibly
dislodge emboli
-
decrease IOP, may perfuse the retina better and dislodge
emboli. IV acetazolamide and topical beta blockers are used and
sometimes anterior chamber paracentesis if needed.
-
ventilation with 100% oxygen was used before but not any more
because of vasoconstriction. Combination of carbon dioxide and
oxygen was also tried to supply enough oxygen to the choroidal
circulation to reach the inner retina, but it was also found to be
toxic to the retina.
-
vasodilators in the retrobulbar space can be given but not
used to avoid hemorrhage
-
surgical cannulation of the supraorbital artery and perfusion
with heparin, papaverine or streptokinase was used in trials
-
IV rt-PA was also used with variable results
-
Experimental studies: ice packs and IV dextromethorphan
The
most serious complication of CRAO is neovascularization and the
development of neovascular glaucoma which occurs in about 16% of
patients and warrants treatment.
Presence of
cholesterol or fibrinoplatelet emboli points to atheromatous disease
and the cardiovascular system should be evaluated. The two main
lesions in the carotid arteries are atheromatous ulceration and
stenosis. Investigation includes: palpation for a weak carotid
pulse, auscultation for a carotid bruit, ophthalmodynamometry (by
external pressure on the sclera and observation of the retinal
artery pulsation), Duplex scanning, digital IV subtraction
angiography, MRA, intra-arterial angiography (but high morbidity)
and screening for risk factors (hypertension, diabetes,
hypercholesterolemia, smoking and hypercoagulable states). Treatment
of carotid disease includes: antiplatelet therapy (aspirin,
aspirin+dipyridamole and clopidogrel), anticoagulation if necessary
and carotid endarterectomy (mainly for symptomatic carotid artery
stenosis >70% with other risk factors for stroke).
|